Abstract

Unilateral injections of 6-hydroxydopamine into the medial forebrain bundle are used extensively as a model of Parkinson's disease. The present experiments sought to identify genes that were affected in the dopamine (DA)–denervated striatum after 6-hydroxydopamine-induced destruction of the nigrostriatal dopaminergic pathway in the rat. We also examined whether a single injection of methamphetamine (METH) (2.5 mg/kg) known to cause changes in gene expression in the normally DA-innervated striatum could still influence striatal gene expression in the absence of DA. Unilateral injections of 6-hydroxydopamine into the medial forebrain bundle resulted in METH-induced rotational behaviors ipsilateral to the lesioned side and total striatal DA depletion on the lesioned side. This injection also caused decrease in striatal serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels. DA depletion was associated with increases in 5-HIAA/5-HT ratios that were potentiated by the METH injection. Microarray analyses revealed changes (± 1.7-fold, p<0.025) in the expression of 67 genes on the lesioned side in comparison to the intact side of the saline-treated hemiparkinsonian animals. These include follistatin, neuromedin U, and tachykinin 2 which were up-regulated. METH administration caused increases in the expression of c-fos, Egr1, and Nor-1 on the intact side. On the DA-depleted side, METH administration also increased the expression of 61 genes including Pdgf-d and Cox-2. There were METH-induced changes in 16 genes that were common in the DA-innervated and DA-depleted sides. These include c-fos and Nor-1 which show greater changes on the normal DA side. Thus, the present study documents, for the first time, that METH mediated DA-independent changes in the levels of transcripts of several genes in the DA-denervated striatum. Our results also implicate 5-HT as a potential player in these METH-induced alterations in gene expression because the METH injection also caused significant increases in 5-HIAA/5-HT ratios on the DA-depleted side.

Highlights

  • Dysfunctions of basal ganglionic structures are the substrates for Huntington’s and Parkinson’s diseases [1,2]

  • Effects of unilateral 6-OHDA-induced medial forebrain bundle (MFB) lesions on striatal gene expression We found significant increases in the expression of Nts, Nmu, and

  • METH injection did not further influence the changes observed in Tac1 and Tac2 mRNA levels on the DAdepleted side, the drug did cause further increases in Nmu expression on the lesioned side, suggesting that Nmu expression is regulated by additional neurotransmitters in the absence of DA innervation

Read more

Summary

Introduction

Dysfunctions of basal ganglionic structures are the substrates for Huntington’s and Parkinson’s diseases [1,2]. Rats that received unilateral injections of 6-hydroxydopamine (6-OHDA) in the nigrostriatal dopaminergic system are used as a model for Parkinson’s disease These animals exhibit ipsilateral rotations after administration of indirect dopamine (DA) agonists and contralateral rotations after direct DA agonists [3,4,5,6,7,8]. These behaviors are related to unilateral changes in the expression of striatal dopaminergic markers [3,4,5,9,10,11,12]. It is not clear to what extent indirect agonists, such as the amphetamines that release DA and other neurotransmitters [21,22,23,24,25] might influence gene expression in the DA-depleted striatum

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call